longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Beta Bionics

BBNX

18.9600.48% ( +0.090 )
Closed: Oct 2, 16:00:01 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit

    prnewswire·1 day ago, 08:08 PM
    BBNX+0.48%
  • Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNX

    prnewswire·1 day ago, 02:00 AM
    BBNX+0.48%
  • BBNX Shareholder Alert: Beta Bionics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt

    prnewswire·Oct 1 at 02:13 PM
    BBNX+0.48%
  • Beta Bionics to report Q3 2026 results, host conference call and webcast

    PUBT·Sep 29 at 12:00 PM
    BBNX+0.48%
  • Beta Bionics, Inc. (BBNX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

    prnewswire·Sep 28 at 06:05 PM
    BBNX+0.48%
  • Beta Bionics (BBNX) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before November 3, 2026 Lead Plaintiff Deadline

    prnewswire·Sep 25 at 03:58 PM
    BBNX+0.48%
  • INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines - BBNX

    prnewswire·Sep 24 at 09:21 PM
    BBNX+0.48%
  • Beta Bionics (NASDAQ: BBNX) Faces Securities Fraud Class Action Amid iLet FDA Compliance -- HBSS

    prnewswire·Sep 24 at 04:13 PM
    BBNX+0.48%
  • Beta Bionics, Inc. (BBNX) Receives a Buy from Truist Financial

    Tip Ranks·Sep 24 at 11:35 AM
    BBNX+0.48%
  • Beta Bionics director Christy Jones disposes of 6,430 common shares worth $147,890

    PUBT·Sep 23 at 09:41 PM
    BBNX+0.48%
  • BBNX Investor Alert: Johnson Fistel Encourages Beta Bionics, Inc. Investors to Contact the Firm Ahead of November 3, 2026 Lead Plaintiff Deadline

    prnewswire·Sep 23 at 06:48 PM
    BBNX+0.48%
  • Beta Bionics partners with Senseonics to integrate iLet bionic pancreas with Eversense 365 CGM

    PUBT·Sep 22 at 11:31 AM
    BBNX+0.48%SENS-0.80%